Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BioNTech SE (Nasdaq: BNTX) today reported financial results for the three months ended March 31, 2026 and provided an update on its corporate progress.
-
International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operational results and related management’s discussion and analysis...
-
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operational results and related...
-
AUSTIN, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Global demand for service robotics is accelerating as industries increasingly turn to automation to address labor...
-
Continued organic quarter over quarter revenue growth with growth of over 30% from Q3 to Q4 2025 (from $529,123 in Q3 2025 to $697,340 for Q4 2025) Earnings per share for Q4, 2025: ($0.10) per...
-
Abaxx has formed Abaxx Labs to engage developers in building smarter markets with open-source tools that promote the use of the Company's ID++ technology.
-
WISeKey Reports Audited Full Year 2025 Financial Results Schedules Conference Call for Monday, May 4 at 9:00am EDT Audited FY 2025 revenue of $19.3 million, representing 62% growth...
-
Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Biologics Outsourcing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The biologics outsourcing market is undergoing...
-
ASCEND Phase 1/2 global clinical trial ongoing, evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types in first-line and previously treated patients; first ADC combination...
-
New York, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight The...